Special Report: Rhythm Biosciences surged more than 30% on Friday after confirming the commercial launch of its ColoSTAT blood test in Australia, enabled by its renewed ISO accreditation. Rhythm ...
Rhythm Biosciences looks to push its ColoSTAT blood test for bowel cancer as a new potential screening tool in England. Rhythm has partnered with the Southern Hub Research Team at the Royal Surrey NHS ...
Host Tylah Tully looks at news from Rhythm Biosciences (ASX:RHY), as it looks to push its ColoSTAT blood test for bowel cancer as a new potential screening tool in England. Rhythm has partnered with ...
Hosted on MSN
New dna test predicts dangerous heart rhythms early
Genetic testing is moving from predicting heart attacks years down the line to flagging dangerous heart rhythms before they ever appear on an electrocardiogram. Instead of waiting for symptoms, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback